FIRDAPSE

This brand name is authorized in Austria, Canada, Estonia, Finland, France, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug FIRDAPSE contains one active pharmaceutical ingredient (API):

1 Amifampridine
UNII 8HF8FIN815 - AMIFAMPRIDINE PHOSPHATE

Amifampridine blocks voltage-dependent potassium channels, thereby prolonging pre-synaptic cell membrane depolarisation. Prolonging the action potential enhances the transport of calcium into the nerve ending. The resulting increase in intra-cellular calcium concentrations facilitates exocytosis of acetylcholine-containing vesicles, which in turn enhances neuromuscular transmission.

Read about Amifampridine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
FIRDAPSE Tablet European Medicines Agency (EU) MPI, EU: SmPC
FIRDAPSE Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N07XX05 Amifampridine N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02502984
Country: EE Ravimiamet Identifier(s): 1455465
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 113885
Country: FR Base de données publique des médicaments Identifier(s): 69935992
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 180363
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6711
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1052910
Country: NL Z-Index G-Standaard, PRK Identifier(s): 96474
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100309728
Country: US FDA, National Drug Code Identifier(s): 69616-211

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.